2-6 June 2018 Toronto
![]() |
![]() |
![]() |
![]() |
P-014 | HOW ETHNIC DONOR INFORMATION SUPPORTS REQUESTS FOR TRANSFUSION | Benjamin Villaseran | ![]() |
![]() |
|||
P-019 | IMPROVEMENTS IN PERIOPERATIVE BLOOD MANAGEMENT FOR PATIENTS ELIGIBLE FOR ELECTRONIC CROSSMATCH | Kerry OBrien | ![]() |
![]() |
|||
P-033 | INTERNATIONALLY STANDARDIZED CODING AND LABELING IN BLOOD TRANSFUSION 24 YEARS LATER | Mónica Freire | ![]() |
![]() |
|||
P-039 | NHSBT SUPPLY OF RARE RED CELLS 2015-2017 | REKHA ANAND | ![]() |
![]() |
|||
P-047 | USAGE OF O RHD NEGATIVE RED CELLS IN FINLAND | Tiia Kivipuro | ![]() |
![]() |
|||
P-051 | IMPACT OF 7-DAY PLATELETS ON INVENTORY MANAGEMENT AT A PEDIATRIC INSTITUTION | Alex Ryder | ![]() |
![]() |
|||
P-053 | CHALLENGES TO PROVIDING BLOOD TO ALLOIMMUNIZED AFRICAN AMERICAN PATIENTS | Margaret Keller | ![]() |
![]() |
|||
P-057 | INNOVATION OF BLOOD TRANSPORTATION SYSTEM IN LUMAJANG BLOOD CENTER | Halimi Maksum | ![]() |
![]() |
|||
P-059 | PATIENT BLOOD MANAGEMENT: ANALYZING THE UTILITY OF UTILIZATION METRICS | James Kelley | ![]() |
![]() |
|||
P-062 | GRANULOCYTES APHERESIS TRANSFUSIONS: THE FRENCH BLOOD MANAGEMENT IN 2016-2017 | Geneviève WOIMANT | ![]() |
![]() |
|||
P-081 | PROCESS IMPROVEMENT TO DECREASE BLOOD PRODUCT WASTAGE AND IMPROVE COLD CHAIN EFFICACY | Ritchelle Tabao | ![]() |
![]() |
|||
P-087 | THE IMPACT OF ANALYTICAL VARIATION OF HEMOGLOBIN MEASUREMENT ON BLOOD DONORS HEMOGLOBIN AND DEFERRAL RATE | Johanna CASTRÉN | ![]() |
![]() |
|||
P-094 | TYPING NON-CONFORMING SAMPLES DUE TO MISLABELING ERRORS FOR IMPROVED DETECTION OF WRONG BLOOD IN TUBE (WBIT) | Ann Wilson | ![]() |
![]() |
|||
P-095 | FEEDBACK OF AN EXTERNAL PROFICIENCY TESTING SCHEME BY INTERLABORATORY COMPARISON FOR QUALITY CONTROL OF BLOOD PRODUCTS AT THE EFS | Stéphane Bégué | ![]() |
![]() |
|||
P-109 | PREDICTING BLOOD DONATION INTENTION: THE IMPORTANCE OF FEAR | Philippe Gilchrist | ![]() |
![]() |
|||
P-114 | PREVALENCE OF CARDIO-VASCULAR RISK FACTORS AMONG BLOOD DONORS IN FRANCE | Anne-Marie Fillet | ![]() |
![]() |
|||
P-119 | AUSTRALIAN BLOOD DONORS AND NON-DONORS VIEWS ON NON-CASH INCENTIVES FOR BLOOD DONATION | Nina Van Dyke | ![]() |
![]() |
|||
P-134 | PROBABILITY TO BE A BLOOD DONOR IN OSLO DEPENDING ON GEOGRAPHICAL FACTORS | Lise Sofie H Nissen-Meyer | ![]() |
![]() |
|||
P-135 | YOUTHTUBE A CASE STUDY ON A BLOOD DONATION SHORT FILM COMPETITION A 2-YEAR REVIEW | Irene van Schalkwyk | ![]() |
![]() |
|||
P-138 | VOLUNTARY NON-REMUNERATED BLOOD DONATION IN THE RUSSIAN FEDERATION | Alexander Chechetkin | ![]() |
![]() |
|||
P-154 | FROM FIRST-TIME PLASMA DONOR TO ESTABLISHING A ROUTINE: HOW DO DONORS DECIDE HOW OFTEN THEY WOULD LIKE TO DONATE PLASMA? | Nina Van Dyke | ![]() |
![]() |
|||
P-196 | CALCIUM IN DRINKING WATER EFFECT ON IRON STORES IN DANISH BLOOD DONORS: RESULTS FROM THE DANISH BLOOD DONOR STUDY (DBDS) | Andreas Stribolt Rigas | ![]() |
![]() |
|||
P-200 | HAEMOGLOBIN REGENERATION IN A FRENCH POPULATION OF NEW DONORS | Jean-Yves Py | ![]() |
![]() |
|||
P-201 | FRENCH ORGANISATION TO PREVENT DONATIONS FROM ANAEMIC DONORS IS QUITE EFFECTIVE | Jean-Yves Py | ![]() |
![]() |
|||
P-205 | STANDING ENHANCES VASOVAGAL SYMPTOMS ELICITED BY STIMULI ASSOCIATED WITH BLOOD BUT NOT OTHER EMOTIONAL STRESSORS | Philippe Gilchrist | ![]() |
![]() |
|||
P-206 | DOES ANTI-HYPERTENSIVE MEDICATION POSE A RISK FOR THE DONOR? | Kathrine M Neuman Johnsen | ![]() |
![]() |
|||
P-228 | WHOLE BLOOD PROCESSING USING DINCH BASED BLOOD CONTAINERS | Konstanze Aurich | ![]() |
![]() |
|||
P-233 | A FIRST AUSTRALIAN STUDY WITH A NATIONAL APPROACH TO SYSTEMATIC TESTING OF DONORS WHEN THEIR WHOLE BLOOD DONATIONS ARE REPEATEDLY DISCARDED DUE TO RED CELL PROCESSING ISSUES | Phillip Mondy | ![]() |
![]() |
|||
P-236 | STUDY OF MAGNESIUM ADDITIVE EFFECT ON RBC UNITS IN COMPARISON WITH UNITS ENRICHED WITH GLUATHIONE | Sima Zolfaghari | ![]() |
![]() |
|||
P-244 | EFFECT OF PRE-PROCESSING HOLDING TIME ON THE QUALITY OF PLASMA RECOVERED FROM LEUKOREDUCED WHOLE BLOOD DONATIONS | William Sheffield | ![]() |
![]() |
|||
P-246 | RED BLOOD CELLS FOR INTRAUTERINE TRANSFUSION: MEETING THE NEED THROUGH PHENOTYPING AND ANTI-CMV ANTIBODY TESTING | Robert Romans | ![]() |
![]() |
|||
P-265 | 2, 3 DIPHOSPHOGLYCERATE CONTENT AND OXYGEN AFFINITY OF HEMANEXT RED BLOOD CELLS STORED UNDER OXYGEN REDUCED CONDITIONS | Samuel Sowemimo-Coker | ![]() |
![]() |
|||
P-271 | TRANSFUSION OF FRESH AND DATE OF EXPIRY RED BLOOD CELLS IN A SHEEP MODEL - AGE DOES NOT MATTER | Gabriela Simonova | ![]() |
![]() |
|||
P-275 | OXYGEN IN RED BLOOD CELL CONCENTRATES: INFLUENCE OF DONORS CHARACTERISTICS, LOCATION AND BLOOD PROCESSING | Michel Prudent | ![]() |
![]() |
|||
P-277 | PROTHROMBIN KNOCKDOWN ABROGATES ANTI-HEMORRHAGIC PROPERTIES OF TRANSFUSABLE PLASMA IN A MOUSE MODEL OF COAGULOPATHY | William Sheffield | ![]() |
![]() |
|||
P-290 | EXPERIENCE OF THE IMPLEMENTATION OF INTERCEPT AMOTOSALEN TREATMENT FOR PLATELETS | Thibaut BOCQUET | ![]() |
![]() |
|||
P-298 | SWIRLING SCORE LOSS IN APHERESIS PLATELETS FOLLOWING THE IMPLEMENTATION OF INTERCEPT PATHOGEN INACTIVATION | Thibaut BOCQUET | ![]() |
![]() |
|||
P-320 | RETENTION OF THROMBIN GENERATION ACTIVITY IN POOLED WHOLE BLOOD-DERIVED PLASMA AFTER AMOTOSALEN-UVA PATHOGEN INACTIVATION AND STORAGE IS INDEPENDENT OF ABO BLOOD GROUPS | catherine RAVANAT | ![]() |
![]() |
|||
P-331 | THAWED PLATELETS AND THAWED PLASMA CAN BE STORED FOR 2 WEEKS AT 4 DEGREES CELSIUS, A POSSIBLE NEW ASSET TO THE TREATMENT OF MAJOR HAEMORRHAGE IN THE PREHOSPITAL SETTING | Femke Noorman | ![]() |
![]() |
|||
P-332 | CRYOPRESERVED SHEEP PLATELETS ARE HEMOSTATICALLY FUNCTIONAL: A SUITABLE PRECLINICAL TRANSFUSION MODEL | Gabriela Simonova | ![]() |
![]() |
|||
P-345 | HUMAN PLATELETS LABELED AT MULTIPLE BIOTIN DENSITIES: A PROMISING APPROACH FOR MONITORING IN VIVO PLATELET SURVIVAL IN CLINICAL TRIALS | catherine RAVANAT | ![]() |
![]() |
|||
P-347 | COLD STORAGES PROVOKES BIOMECHANICAL CHANGES AND AGGREGATE FORMATION IN PLATELET CONCENTRATES | Konstanze Aurich | ![]() |
![]() |
|||
P-352 | COMPARISION STUDY OF THE NEWLY LAUNCHED ROCHE ELECSYS INFECTIOUS DISEASE PARAMETERS ON COBAS E 801 IN BLOOD DONOR SCREENING | Caroline Tinguely | ![]() |
![]() |
|||
P-354 | HEV RNA SCREENING OF BLOOD DONATIONS BY A COMMERCIAL TRANSCRIPTION-MEDIATED AMPLIFICATION ASSAY (TMA): LINEAR CORRELATION BETWEEN TMA VALUES AND HEV VIRAL LOAD | Sílvia SAULEDA | ![]() |
![]() |
|||
P-362 | A SAFE SCREENING ALGORITHM FOR INDIVIDUAL NUCLEIC ACID TESTING (ID-NAT): 10 YEARS OF EXPERIENCE IN A LOW ENDEMIC COUNTRY | Martin Stolz | ![]() |
![]() |
|||
P-371 | USE OF A NOVEL TECHNOLOGY TO EFFECTIVELY WASH THE SAMPLE PIPETTOR DURING AUTOMATED BLOOD SCREENING ON THE ALINITY S | Lynn Martin | ![]() |
![]() |
|||
P-372 | INDUCTION HEATING: AN ADVANCED WASHING TECHNOLOGY TO PRESERVE SAMPLE INTEGRITY ON ALINITY S FOR TRANSFER TO NAT INSTRUMENTS | Pathik Soni | ![]() |
![]() |
|||
P-373 | ABBOTT ALINITY S ASSAYS ROBUSTNESS TO BIOTIN INTERFERENCE | Lynn Martin | ![]() |
![]() |
|||
P-375 | PERFORMANCE OF NEW ASSAYS FOR HTLV I/II, HBC AND CHAGAS ON THE FULLY AUTOMATED ABBOTT ALINITY S SYSTEM | Ben Marchlewicz | ![]() |
![]() |
|||
P-376 | PERFORMANCE OF NEW ASSAYS FOR HBSAG, HCV, AND HIV AG/AB COMBO ON THE FULLY AUTOMATED ABBOTT ALINITY S SYSTEM | Ben Marchlewicz | ![]() |
![]() |
|||
P-404 | HEPATITIS CORE ANTIBODY SCREEING IN BLOOD DONORS IN SAUDI ARABIA | Omer Alsaweed | ![]() |
![]() |
|||
P-411 | BLOOD TRANSFUSION SAFETY AND ELIMINATION OF HEPATITIS C IN GEORGIA | Evan Bloch | ![]() |
![]() |
|||
aP-440 | IS PARVOVIRUS B19 A CONCERN FOR BLOOD SAFETY IN AUSTRALIA? | Helen Faddy | ![]() |
![]() |
|||
P-440 | INACTIVATION OF YELLOW FEVER VIRUS IN PLASMA AND IN PLATELET CONCENTRATES FOLLOWING TREATMENT WITH THE THERAFLEX PATHOGEN INACTIVATION (PI) TECHNOLOGIES | Helen Faddy | ![]() |
![]() |
|||
P-473 | EDUCATING RARE DONORS WHY IS THIS IMPORTANT? | Tanya Powley | ![]() |
![]() |
|||
P-480 | ABO AND RH PHENOTYPE FREQUENCIES IN DRUZE POPULATION IN NORTHERN ISRAEL | Hanna Morani | ![]() |
![]() |
|||
P-485 | AN ANTIBODY AGAINST A NOVEL HIGH INCIDENCE ANTIGEN IN THE INDIAN BLOOD GROUP SYSTEM | Henny Christine | ![]() |
![]() |
|||
P-492 | HEMOLYTIC TRANSFUSION REACTION DUE TO AN ANTI-H ANTIBODY IN A SICKLE CELL DISEASE PATIENT | Elena Lazarova | ![]() |
![]() |
|||
P-504 | SOFTWARE ASSISTED ANTIBODY IDENTIFICATION - IH-ABID | Paul Aerts | ![]() |
![]() |
|||
P-508 | INTRODUCTION OF AUTOMATED HIGH TITRE ANTI-A AND/OR ANTI-B SCREENING IN AUSTRALIAN BLOOD DONORS | Tanya Powley | ![]() |
![]() |
|||
P-520 | EXPERIENCE IN THE IMPLEMENTATION OF TYPE AND SCREEN - ABBREVIATED CROSSMATCH PROCEDURE (TAS-CIS) - IN A BLOOD BANK OF A HOSPITALS EMERGENCY CENTER IN LIMA PERU | Elizabeth CARRILLO | ![]() |
![]() |
|||
P-525 | NOVEL RECOMBINANT CD38 FOR USE IN PRETRANSFUSION DIAGNOSTICS | Matteo Binda | ![]() |
![]() |
|||
P-526 | COMPLICATION IN BLOOD COMPATIBILITY TESTING WITH DARATUMUMAB TREATMENT IN MULTIPLE MYELOMA: A CASE REPORT | ANURAG GUPTA | ![]() |
![]() |
|||
P-529 | TWO CASES OF CAUCASIAN BOMBAY AND THREE CASES OF PARA-BOMBAY PHENOTYPE REVEALED FIVE NOVEL FUT1 ALLELES | Hein Hustinx | ![]() |
![]() |
|||
P-553 | GENOTYPING PANEL DESIGNED TO IDENTIFY BLOOD DONORS LACKING HIGH PREVALENCE RH ANTIGENS | Margaret Keller | ![]() |
![]() |
|||
P-556 | RHD AND RHCE ALLELES IN BRAZILIAN SICKLE CELL DISEASE PATIENTS WITH UNEXPLAINED RH ANTIBODIES | CARLA DINARDO | ![]() |
![]() |
|||
P-577 | ASSOCIATION BETWEEN ANTI-D IMMUNOGLOBULIN DEVELOPMENT IN IMMUNISED BLOOD DONORS AND THE RED BLOOD CELL PHENOTYPE | Joanne Tan | ![]() |
![]() |
|||
P-583 | RHD TYPING AMBIGUITIES IN MERGING SEROLOGICAL AND MOLECULAR DATA THE DETERMINING CONTRIBUTION OF GENE SEQUENICING | TOMMASO MANCUSO | ![]() |
![]() |
|||
P-584 | UTILITY OF RED BLOOD CELL GENOTYPING OF BLOOD DONORS | Margaret Keller | ![]() |
![]() |
|||
P-596 | ANTIBODY FORMATION PREDICTION IN TRANSFUSION-DEPENDENT PATIENTS | Joanne Tan | ![]() |
![]() |
|||
P-625 | DONOR ANTI-HNA-3A, ANTI-HLA CLASS-I AND ANTI-HLA CLASS-II ANTIBODIES INDUCE NEUTROPHIL- AND MONOCYTE-MEDIATED HLMVEC DAMAGE IN A TWO-INSULT IN VITRO MODEL | John-Paul Tung | ![]() |
![]() |
|||
P-663 | CORRELATION BETWEEN CONVENTIONAL COAGULATION TESTS AND ROTEM IN CHILDREN UNDERGOING CRANIOSYNOSTOSIS SURGERY | RANJAN JOSHI | ![]() |
![]() |
|||
P-687 | ERYTHROCYTAPHERESIS,USEFUL ADJUNCT THERAPY IN PATIENTS WITH SEVERE MALARIA.HOSPITAL-BASED BLOOD BANK EXPERIENCE | M. Isabel GONZALEZ MEDINA | ![]() |
![]() |
|||
P-695 | IRONING OUT ANAEMIA IN PREGNANT WOMEN | Kristy Evans | ![]() |
![]() |
|||
P-697 | FERRITIN SCREENING FOR PATIENT BLOOD MANAGEMENT IN PREGNANCY | Philip Crispin | ![]() |
![]() |
|||
P-708 | PATIENT BLOOD MANAGEMENT STRATEGIES ASSOCIATED WITH REDUCED TRANSFUSION RATES IN ELECTIVE ORTHOPAEDIC SURGICAL PATIENTS | Leanna Pickles | ![]() |
![]() |
|||
P-711 | AGE OF BLOOD DOES NOT IMPACT OF THE FREQUENCY OF BLOOD TRANSFUSION IN MYELODYSPLASTIC SYNDROME | Philip Crispin | ![]() |
![]() |
|||
P-719 | FRESH FROZEN PLASMA STORAGE DURATION ASSOCIATED WITH SMALL INCREASED IN-HOPSITAL MORTALITY RISK | John-Paul Tung | ![]() |
![]() |
|||
P-758 | ACUTE HAEMOLYTIC TRANSFUSION REACTION DUE TO ANTI-MT | Vincent Claes | ![]() |
![]() |
|||
P-770 | HAEMOVIGIL, A NEW SYSTEM TO PREVENT WRONG BLOOD IN TUBE (WBIT) AND TRANSFUSION ERRORS DUE TO PATIENT MIS-IDENTIFICATION: ONE YEAR EXPERIENCE AT A TERTIARY HOSPITAL IN INDIA | Gautam Wankhede | ![]() |
![]() |
|||
P-772 | TACO: HOW DO WE PROMOTE AWARENESS AND REPORTING? | Linley Bielby | ![]() |
![]() |
|||
P-797 | BLOOD UTILIZATION AND IMPACT OF CHRONIC TRANSFUSION THERAPY (CTT) IN A LARGE COHORT OF BRAZILIAN SICKLE CELL DISEASE (SCD) PATIENTS | shannon kelly | ![]() |
![]() |
|||
P-814 | RED BLOOD CELL TRANSFUSION ADEQUACY INDEX AS TOOL FOR IMPROVING PATIENT BLOOD MANAGEMENT PROGRAM. | Gustavo Duarte | ![]() |
![]() |
|||
P-829 | THE EFFECT OF CD34-PRE-COUNT, GENDER, AGE AND TYPE OF COLLECTION PROCEDURE ON COLLECTION EFFICIENCY IN STEM CELL COLLECTION FOR MULTIPLE MYELOMA | Francis Swaneveld | ![]() |
![]() |
|||
P-832 | THE IMPACT OF THE CRYOPRESERVED PERIOD OF CB UNITS IN THE CHOICE FOR CB TRANSPLANTATION: THE CLINICIANS WOULD PREFER CB UNITS WITH SHORTER CRYOPRESERVED PERIODS THAN LONGER CB UNITS? | Hye Ryun Lee | ![]() |
![]() |
|||
P-854 | PERFORMANCE EVALUATION OF THE SPECTRA OPTIA APHERESIS SYSTEM MONONUCLEAR CELL COLLECTION FOR AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION | tamima jisr | ![]() |
![]() |
2-6 June 2018 Toronto
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|